Cellens Inc.
PrivateLast Round
Seed
Dec 23, 2025
Total Funding Raised
$6.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cellens Inc. operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Seed round in December 2025.
Cellens Inc. is a healthcare company that develops a cell surface scanning platform designed for noninvasive detection of bladder cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellens Inc. Comparables
Compare Cellens Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VitaDX | 81% | |
| Nucleix | 79% | |
| Nonagen Bioscience Corporation | 79% |
For institutional investors. Book with your work email.
Cellens Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cellens Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CANCER FUND | Seed |
| BrightEdge | Seed |
| Tufts University | Seed |
| TiE Boston Angels | Seed |
| Blackwood Healthcare Breakthroughs | Seed |
| SOSV | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 78% MoM.
- Jan 21, 2026
Grew 36% QoQ from 11 to 15 employees.
For institutional investors. Book with your work email.
Cellens Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cellens Inc.'s valuation, stock price, and market status.
Is Cellens Inc. a public or private company?
Cellens Inc. is a private company.
What is the current stock price of Cellens Inc.?
Cellens Inc. is a private company, so its shares have no public market price. Caplight tracks Cellens Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cellens Inc. worth (valuation)?
Valuation information for Cellens Inc. is not publicly available.
Can I buy Cellens Inc. stock?
Cellens Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cellens Inc.'s last funding round?
Cellens Inc.'s most recent funding round was Seed on December 23, 2025.
Who are the main investors in Cellens Inc.?
Key investors in Cellens Inc. include SOSV.
Will Cellens Inc. IPO soon?
No public IPO plans have been announced for Cellens Inc..
How can I track Cellens Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Cellens Inc.'s shares on secondary markets.